Loading
Latest filing published 27 May 2026 for Co-Diagnostics, Inc.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Eugene Durenard is a declared insider of Co-Diagnostics, Inc. (board member), with filings sourced from SEC (Form 4). In total, 11 filings cover trades dated from 8 September 2021 to 23 May 2026.
On the market, this insider has only sold: 1 sale, €18k in total. Other entries cover 10 share grants.
The latest filing, published on 27 May 2026, reports a share grant in Co-Diagnostics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
11 of 11 declarations